<DOC>
	<DOCNO>NCT00988156</DOCNO>
	<brief_summary>The purpose study examine efficacy safety Eslicarbazepine acetate ( BIA 2-093 ) give anti-epileptic drug treat child partial seizure whose condition control drug treatment .</brief_summary>
	<brief_title>Eslicarbazepine Acetate ( BIA 2 093 ) Therapy Refractory Partial Seizures Children</brief_title>
	<detailed_description>Partial epilepsy , commonest form epilepsy , difficult condition treat many patient continue symptom despite try several medication . Lack efficacy adverse effect commonly associate current anti-epileptic drug . This study examine efficacy addition safety tolerability new anti-epileptic drug , Eslicarbazepine acetate ( BIA 2-093 ) , adjunctive therapy refractory partial seizure child . The primary analysis variable : - The responder rate ( proportion patient least 50 % reduction standardise seizure frequency ) - The relative reduction standardise seizure frequency</detailed_description>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsies , Partial</mesh_term>
	<mesh_term>Eslicarbazepine acetate</mesh_term>
	<criteria>girl childbearing potential follow reliable medically acceptable contraceptive method throughout study diagnosis epilepsy least 6 month prior enrolment least 4 partialonset seizure last month prior enrolment despite stable therapy adequate dosage 1 2 AEDs least 4 partialonset seizure 4week interval 8week baseline period previous treatment three AEDs , maximum tolerated dos , least one month , without seizure control current treatment 1 2 AEDs ( except oxcarbazepine ) ; present , vagus nerve stimulation consider AED stable dose regimen AEDs 8week baseline period cooperation willingness complete aspect study , include hospitalisation require write informed consent participate study accordance local legislation primarily generalise seizure baseline seizure frequency substantially different usual seizure frequency know progressive neurological disorder history status epilepticus within 3 month prior enrolment seizure nonepileptic origin LennonGastaut West syndrome Major psychiatric disorder Previous treatment study Eslicarbazepine acetate</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Epilepsy</keyword>
	<keyword>Partial</keyword>
	<keyword>Refractory</keyword>
	<keyword>Children</keyword>
	<keyword>Adolescents</keyword>
	<keyword>Adjunctive</keyword>
	<keyword>Randomised</keyword>
	<keyword>Double-blind</keyword>
	<keyword>Placebo-controlled</keyword>
	<keyword>Parallel-group</keyword>
</DOC>